Rapid sequence induction medications: an update.
Frakes
Michael A
MA
LIFE STAR/Hartford Hospital, Hartford, CT 06102-5037, USA. mfrakes@harthosp.org
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000777:Anesthetics / Q000627:therapeutic use*; D001285:Atropine / Q000627:therapeutic use; D001463:Barbiturates / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D016529:Emergency Nursing / Q000379:methods*; D005283:Fentanyl / Q000627:therapeutic use; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use*; D007442:Intubation, Intratracheal / Q000451:nursing*; D008012:Lidocaine / Q000627:therapeutic use; D009294:Narcotics / Q000627:therapeutic use; D009466:Neuromuscular Blocking Agents / Q000627:therapeutic use*; D010102:Oxygen Inhalation Therapy / Q000379:methods; D010243:Paralysis / Q000139:chemically induced; D011412:Propanolamines / Q000627:therapeutic use; D013390:Succinylcholine / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000777:Anesthetics; D001463:Barbiturates; D006993:Hypnotics and Sedatives; D009294:Narcotics; D009466:Neuromuscular Blocking Agents; D011412:Propanolamines; D001285:Atropine; D008012:Lidocaine; D013390:Succinylcholine; C036604:esmolol; D005283:Fentanyl